Product Pipeline
In parallel to exploring alternative diagnostic solutions for the reliable early detection of HIE – historically the focus of the Company - we are pursuing further novel opportunities in prenatal testing and infant health with the intention of creating a high-value portfolio that balances biological, technological, and market risks.
Due to ongoing partnering discussions and intellectual property-related activities, further details will be disclosed in the near future.